Liver tumors

Seminars in Pediatric Surgery

Volumn 9, Issue 4, 2000, Pages 196-208

  Stringer, Mark D ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; IFOSFAMIDE; VINCRISTINE;

CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; HAMARTOMA; HEMANGIOMA; HEPATITIS B; HEPATOBLASTOMA; HISTOPATHOLOGY; HUMAN; LIVER ADENOMA; LIVER CANCER; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER TRANSPLANTATION; LIVER TUMOR; PRIORITY JOURNAL; REVIEW;

EID: 0033638904     PISSN: 10558586     EISSN: None     Source Type: Journal    
DOI: 10.1053/spsu.2000.18844     Document Type: Article

References (164)

1. Malignant hepatic tumours in children Incidence, clinical features and etiology
2. Childhood cancer
3. Primary malignant liver tumors in childhood Assessment of resectability with high-field MR and comparison with CT
4. Mildenberger H Liver tumors in neonates and very young infants Diagnostic pitfalls and therapeutic problems
5. Mesenchymal hamartoma of the liver Report of 30 cases and a review of the literature
6. Prenatally detected hepatic hamartoma Another cause of non-immune hydrops
7. Primary hepatic tumors of childhood
8. Mesenchymal hamartoma of the liver Case report and literature review
9. Mesenchymal hamartoma of the liver DNA flow cytometric analysis of eight cases
10. Malignant potential of mesenchymal hamartoma An unrecognised risk
11. Hepatic undifferentiated (embryonal) sarcoma arising in a mesenchymal hamartoma
12. Malignant transformation of mesenchymal hamartoma of the liver Case report and review of the literature
13. Mesenchymal hamartoma of the liver
14. Focal nodular hyperplasia and hepatic adenoma A review of eight cases in the pediatric age group
15. Focal nodular hyperplasia of the liver A study of 21 pediatric cases
16. Focal nodular hyperplasia and adenoma of the liver A pediatric experience
17. Prenatal diagnosis of focal nodular hyperplasia of the liver
18. Radiological features of focal nodular hyperplasia of the liver in children
19. Polycythemia secondary to focal nodular hyperplasia
20. Association of focal nodular hyperplasia and hepatic hemangioma
21. Benign and malignant tumours
22. CT and MR appearance of focal nodular hyperplasia of the liver in children with biliary atresia
23. Multiple focal nodular hyperplasia of the liver associated with hemihypertrophy and vascular malformations
24. Patent ductus venosus associated with tumor-like lesions of the liver in a young girl
25. Congenital absence of the portal vein associated with focal nodular hyperplasia of the liver and cystic dysplasia of the kidney
26. Focal nodular hyperplasia of the liver in children Review of follow-up and outcome
27. Focal nodular hyperplasia Natural course observed with CT and MRI
28. Infantile hepatic hemangioendothelioma The role of surgery
29. Fetal tumors associated with hydrops The role of the pediatric surgeon
30. Infantile hepatic hemangioendothelioma with subsequent malignant degeneration
31. Hepatic hemangioendothelioma Clinical experience and management strategy
32. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy
33. Hemangioendothelioma of the liver in infants
34. Special compression sutures A new surgical technique to achieve a quick decrease in shunt volume caused by diffuse hemangiomatosis of the liver
35. Infantile hepatic hemangiomas Clinical features, radiologic investigations, and treatment of 20 patients
36. Benign liver tumors in children A 25-year experience
37. Management of massive hepatic hemangiomas in infants and children A review of 13 cases
38. Orthotopic liver transplantation for type 2 infantile haemangioendothelioma
39. Hemangiopericytoma of the liver Immunohistochemical observations, expression of angiogenic factors, and review of the literature
40. Lymphangioendothelioma of the liver in a neonate
41. Hepatic and splenic lymphangiomatosis with skeletal involvement Report of a case and review of the literature
42. Hepatic adenoma in the pediatric age group Clinicopathological observations and assessment of cell proliferative activity
43. Liver adenomatosis Reappraisal, diagnosis, and surgical management
44. Solitary nonparasitic cysts of the liver The Boston Children's experience
45. Congenital solitary cyst of neonatal liver
46. Hepatobiliary cystadenoma A rare hepatic tumor in a child
47. Peliosis hepatis with initial presentation as acute hepatic failure and intraperitoneal hemorrhage in children
48. Nodular regenerative hyperplasia of the liver in children
49. Nodular regenerative hyperplasia of the liver Case report of a 13-year-old girl and review of the literature
50. Abdominal inflammatory myofibroblastic tumors in children
51. Inflammatory pseudotumor of the liver in Kostmann's disease
52. Inflammatory pseudotumor of the liver in children A case report and review of the literature
53. Seasonal variations in the diagnosis of childhood cancer in the United States
54. Improved outcome for children with hepatoblastoma
55. Extreme thrombocytosis as a diagnostic clue to hepatoblastoma
56. Hepatoblastoma, thrombocytosis and increased thrombopietin
57. Immunohistochemical and ultrastructural study on erythropoiesis in hepatoblastoma
58. The prognostic evaluation of hypercholesterolemia in infants and children with hepatoblastoma
59. Malignant liver and bile duct tumors
60. Hepatoblastoma and polyposis coli (Familial adenomatous polyposis)
61. Hepatoblastoma in a child with the fetal alcohol syndrome
62. Loss of alleles on the short arm of chromosome 11 in a hepatoblastoma from a child with Beckwith Wiedemann syndrome
63. Hepatoblastoma in a child with neurofibromatosis
64. Prader-Wilh syndrome with deletion of 15q 11, q13 associated hepatoblastoma
65. Multiple hepatoblastomas associated with trisomy 18 in a 3-year-old girl
66. Increased risk of hepatoblastoma among immature children with a lower birth weight
67. Antenatal therapeutic drug exposure and fetal/neonatal tumours Review of 89 cases
68. Hepatoblastoma incidence in the United States from 1973 to 1992
69. Alpha-fetoprotein (AFP) levels in normal children
70. Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome A report from the Children's
71. Ultrasound of primary hepatic tumors in childhood
72. The continued value of angiography in planning surgical resection of benign and malignant hepatic tumors in children
73. Preoperative chemotherapy in hepatoblastoma
74. The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapy
75. A common language for childhood liver tumors
76. SIOPEL 1 The first hepatoblastoma (HB) and hepatocellular carcinoma (HCC) study -Preliminary results
77. Hepatoblastoma Attempt at characterisation of histological subtypes
78. Hepatoblastoma A clinical and pathological study of 54 cases
79. Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma
80. Chemotherapy effects on hepatoblastoma A histological study
81. Cytogenetic analysis of hepatoblastoma Hypothesis of cytogenetic evolution in such tumors and results of a multicentric study
82. Loss of maternal alleles on chromosome arm 11p in hepatoblastoma
83. Activation of betacatenin in epithelial and mesenchymal hepatoblastomas
84. Treatment of liver tumors in children
85. Liver tumours
86. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: A report from the Childrens Cancer Study Group
87. Cinsplatin, vincristine, and fluorouracil therapy for hepatoblastoma A Pediatric Oncology Group study
88. Preoperative chemotherapy - Cisplatin (PLA) and doxorubicin (DO) PLADO for the treatment of hepatoblastoma (HB) and hepatocellular carcinoma (HCC) - Results after 2 years follow-up
89. Improved survival in infants and children with primary malignant liver tumors
90. Thirty years of experience with pediatric primary malignant liver tumors
91. Hepatoblastoma and hepatocarcinoma in children Analysis of a series of 29 cases
92. Primary hepatic tumours in children A 26-year review
93. Effectiveness and toxicity of cisplatin and doxorubicin (PLADO) in childhood hepatoblastoma and hepatocellular carcinoma. A SlOP pilot study
94. Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma A report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94
95. Conversion of unresectable to resectable hepatoblastoma and long-term follow-up study
96. Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma Study Committee of the Cooperative Paediatric Liver Tumour Study HB 89 of the German Society for Paediatric Oncology and Haematology
97. Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma A report from the German Cooperative Pediatric Liver Tumor Study HB- 89
98. Is there a place for radiation therapy in the management of hepatoblastoma and hepatocellular carcinomas in children?
99. Major hepatic resections for neoplasia in children
100. Liver resections
101. Extended left hepatectomy (left hepatic trisegmentectomy) in childhood
102. Cavitron ultrasonic surgical aspirator (CUSA) in liver resection
103. Hepatic resections for primary and metastatic tumors using the ultrasonic surgical dissector
104. Tolerance of the human liver to prolonged normothermic ischemia
105. Anaesthetic considerations in liver tumor resection in children
106. Major hepatic tumor resection using profound hypothermia and circulation arrest
107. Technique and prelimmary results of extracorporeal liver surgery (bench procedure) and of surgery on the in situ perfused liver
108. A hepatoblastoma originating in the caudate lobe radically resected with the inferior vena cava
109. Preoperative chemotherapy in 'unresectable' hepatoblastoma
110. Fatal intraoperative tumor embolism in a child with hepatoblastoma
111. Fatal refractory hyperkalaemia due to tumor lysis during primary resection for hepatoblastoma
112. Major hepatic resections in children
113. Liver regeneration in children after major hepatectomy for malignancy - Evaluation using a computer-aided technique of volume measurement
114. Long-term hepatic regeneration and function in infants and children following liver resection
115. Early use of cisplatin is safe after partial hepatectomy
116. Liver transplantation for hepatoblastoma The American experience
117. Resection, including transplantation, for hepatoblastoma and hepatocellular carcinoma impact on survival
118. Transplantation for unresectable liver tumors in children
119. Orthotopic liver transplantation for unresectable hepatoblastoma A single center's experience
120. Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence
121. Preoperative chemotherapy, major liver resection, and transplantation for primary malignancies in children
122. Results of liver transplantation in children with unresectable liver tumors
123. Alpha Feto Protein (AFP) monitoring of response to adriamycin in hepatoblastoma
124. Aggressive excision of pulmonary metastases is warranted in the management of childhood hepatic tumors
125. Relapse pattern in childhood hepatoblastoma treated with pre-operative chemotherapy (PLADO) in the SIOPEL 1 study
126. Prolonged survival following multiple thoracotomies for metastatic hepatoblastoma
127. Hepatoblastoma An analysis of the relationship between morphologic subtypes and prognosis
128. Complete disappearance of unresectable hepatoblastoma by continuous infusion therapy through hepatic artery
129. Use of intrahepatic chemotherapy to treat advanced pediatric hepatic malignancies
130. Intrahepatic arterial injections of cisplatin-phosphatidylcholine-lipidol suspension in two unresectable hepatoblastoma cases
131. Feasibility and toxicity of chemoembolization for children with liver tumors
132. Immunotargeting chemotherapy for AFP producing pediatric liver cancer using the conjugates of anti-AFP antibody and anti-tumor agents
133. Hepatocellular carcinoma in children
134. Liver malignancy after parenteral nutrition
135. Hepatocellular carcinoma as second malignant neoplasms in successfully treated Wilms' tumor patients
136. Hepatocellular carcinoma complicating biliary cirrhosis caused by biliary atresia Report of a case
137. Primary malignant tumor of liver in infants and children in Taiwan
138. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children Taiwan Childhood Hepatoma Study Group
139. Hepatocellular carcinoma in children Clinical review and comparison with adult cases
140. Transcobalamin I as a 'marker' for fibrolamellar hepatoma
141. Aggressive surgical management of fibrolamellar hepatocellular carcinoma
142. Results of 280 liver resections for hepatocellular carcinoma
143. Female sex hormone receptor status in advanced hepatocellular carcinoma and outcome after surgical resection
144. Nonresectional therapies for hepatocellular carcinoma
145. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection
146. Ablative approach for primary liver cancer
147. Primitive malignant nonepithelial hepatic tumors in children
148. Undifferentiated sarcoma of the liver in childhood Morphology, flow cytometry and literature review
149. Mesenchymoma of the liver in childhood 5 years survival after combined-modality treatment
150. Rhabdomyosarcoma of the biliary tree in childhood
151. Hepatic undifferentiated (embryonal) sarcoma and rhabdomyosarcoma in children
152. Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma
153. Embryonal rhabdomyosarcoma of the common bile duct
154. Spontaneous rupture of a malignant rhabdoid tumor of the liver
155. Hepatic angiosarcoma in a child Successful therapy with surgery and adjuvant chemotherapy
156. Liposarcoma of hepatic hilum in childhood Report of a case and review of the literature
157. Primary endodermal sinus (yolk sac) tumor of the liver
158. Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies
159. Primary endodermal sinus (yolk sac) tumor of the falciform ligament
160. The role of subfractionation of alpha-fetoprotein in the treatment of pediatric surgical patients
161. Primary hepatic or hepatosplenic non-Hodgkin's lymphoma in children
162. Review of 17 IVS neuroblastoma patients at the Children's Hospital of Philadelphia